ChemoMetec A/S (CPH:CHEMM)
Denmark flag Denmark · Delayed Price · Currency is DKK
515.00
-10.00 (-1.90%)
Sep 25, 2026, 4:59 PM CET

ChemoMetec Revenue

In the fiscal year ending June 30, 2026, ChemoMetec had annual revenue of 511.06M DKK with 3.12% growth. ChemoMetec had revenue of 262.04M in the half year ending June 30, 2026, with 25.94% growth.

Revenue
511.06M
Revenue Growth
+3.12%
P/S Ratio
17.33
Revenue / Employee
2.94M
Employees
174
Market Cap
8.86B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Jun 30, 2026511.06M15.49M3.12%
Jun 30, 2025495.57M88.22M21.66%
Jun 30, 2024407.35M-34.92M-7.90%
Jun 30, 2023442.27M15.11M3.54%
Jun 30, 2022427.16M146.03M51.95%
Jun 30, 2021281.13M67.03M31.31%
Jun 30, 2020214.10M38.59M21.99%
Jun 30, 2019175.51M62.83M55.75%
Jun 30, 2018112.69M22.36M24.75%
Jun 30, 201790.33M5.10M5.98%
Jun 30, 201685.23M23.99M39.18%
Jun 30, 201561.24M16.01M35.40%
Jun 30, 201445.23M3.83M9.26%
Jun 30, 201341.40M2.20M5.60%
Jun 30, 201239.20M1.97M5.29%
Jun 30, 201137.23M4.62M14.18%
Jun 30, 201032.61M556.00K1.73%
Jun 30, 200932.05M3.57M12.53%
Jun 30, 200828.48M6.17M27.67%
Jun 30, 200722.31M7.71M52.77%
Jun 30, 200614.60M695.00K5.00%
Jun 30, 200513.91M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Novo Nordisk329.43B
Coloplast28.44B
Genmab27.03B
Demant24.63B
GN Store Nord16.46B
ALK-Abelló6.83B
Embla Medical6.44B
Bavarian Nordic6.34B
Revenue Rankings